Jeong Hwan Kim

Dr. Jeong Hwan Kim


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2015 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
SLSang Pyo Lee
Sang Pyo Lee
JKJeong Hwan Kim
Jeong Hwan Kim
ISIn‐Kyung Sung
In‐Kyung Sung
SLSun‐Young Lee
Sun‐Young Lee
HPHyung Seok Park
Hyung Seok Park
HHHye Seung Han
Hye Seung Han

13 December 2014 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
MHMi Jin Hong
Mi Jin Hong
JKJeong Hwan Kim
Jeong Hwan Kim
SLSun-Young Lee
Sun-Young Lee
ISIn-Kyung Sung
In-Kyung Sung
HPHyung Seok Park
Hyung Seok Park
CSChan Sup Shim
Chan Sup Shim

18 July 2012 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
JYJung Yoon Yoon
Jung Yoon Yoon
JKJeong Hwan Kim
Jeong Hwan Kim
JLJi Young Lee
Ji Young Lee
SHSung Noh Hong
Sung Noh Hong
SLSun-Young Lee
Sun-Young Lee
HHHye Seung Han
Hye Seung Han

1 October 2012 in Hepatogastroenterology
Verified
Journal Article
Closed access
TSTae Ho Seo
Tae Ho Seo
JKJeong Hwan Kim
Jeong Hwan Kim
SKSoon Young Ko
Soon Young Ko
SHSung Noh Hong
Sung Noh Hong
SLSun-Young Lee
Sun-Young Lee
HHHye Seung Han
Hye Seung Han
Cytomegalovirus (CMV) colitis occurs rarely in immunocompetent patients and little detail is known about the clinical features, endoscopic findings and prognosis of CMV colitis in immunocompetent patients. The aim of this study was to investigate the clinical and endoscopic features of CMV colitis and its prognosis in immunocompetent patients. We retrospectively reviewed the medical records and the endoscopic findings of twelve immunocompetent patients who were diagnosed with CMV colitis by immunostaining for CMV antibodies based on the histological examination of tissue biopsies obtained during colonoscopy. The patients were six men and six women and their median age was 66 years (range 44-88). Patients infected with CMV colitis had comorbidities including diabetes mellitus (n=4), chronic renal failure (n=3) and ischemic heart disease (n=2). The most common initial presenting symptom was gastrointestinal bleeding (n=7) and the associated symptoms were diarrhea and abdominal pain. Endoscopic examination showed three types: well-demarcated ulcerative type (n=6), ulceroinfiltrative type (n=3), and pseudomembranous colitis-associated type (n=3). All patients were treated with an antiviral agent (ganciclovir) within two weeks following onset of main presenting symptom and all showed clinical and endoscopic improvement except one died later from severe pneumonia. CMV colitis in immunocompetent patients presented in older patients and in those with other comorbidities. Gastrointestinal bleeding was the most common initial presentation. Despite aggressive clinical manifestations, the prognosis of CMV colitis is good if diagnosed and treated early.

1 January 2021 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
JKJi Yeon Kim
Ji Yeon Kim
SLSun-Young Lee
Sun-Young Lee
HKHyobin Kim
Hyobin Kim
JKJeong Hwan Kim
Jeong Hwan Kim
ISIn-Kyung Sung
In-Kyung Sung
HPHyung Seok Park
Hyung Seok Park
Kim JY, et al. Yonsei Med J. 2021 Aug;62(8):708-716. https://doi.org/10.3349/ymj.2021.62.8.708

22 June 2021 in Gut and Liver
Verified
Journal Article
Open access
PDF file
BYByong Duk Ye
Byong Duk Ye
SHSung Noh Hong
Sung Noh Hong
SSSeung In Seo
Seung In Seo
YKYe-Jee Kim
Ye-Jee Kim
JCJae Myung Cha
Jae Myung Cha
TGthe Songpa-Kangdong Inflammatory Bowel Disease (SK-IBD) Study Group
the Songpa-Kangdong Inflammatory Bowel Disease (SK-IBD) Study Group
Byong Duk Ye, Sung Noh Hong, Seung In Seo, Ye-Jee Kim, Jae Myung Cha, Kyoung Hoon Rhee, Hyuk Yoon, Young-Ho Kim, Kyung Ho Kim, Sun Yong Park, Seung Kyu Jeong, Ji Hyun Lee, Hyunju Park, Joo Sung Kim, Jong Pil Im, Sung Hoon Kim, Jisun Jang, Jeong Hwan Kim, Seong O Suh, Young Kyun Kim, Sang Hyoung Park, and Suk-Kyun Yang, on behalf of the Songpa-Kangdong Inflammatory Bowel Disease (SK-IBD) Study Group. Gut and Liver 2022;16:216-27. https://doi.org/10.5009/gnl210044